Correction to: Skin rash following Administration of Apalutamide in Japanese patients with Advanced Prostate Cancer: an
- PDF / 708,840 Bytes
- 2 Pages / 595.276 x 790.866 pts Page_size
- 79 Downloads / 248 Views
Open Access
CORRECTION
Correction to: Skin rash following Administration of Apalutamide in Japanese patients with Advanced Prostate Cancer: an integrated analysis of the phase 3 SPARTAN and TITAN studies and a phase 1 open‑label study Hiroji Uemura1, Yosuke Koroki2* , Yuki Iwaki3, Keiichiro Imanaka4, Takeshi Kambara5, Angela Lopez‑Gitlitz6, Andressa Smith6 and Hirotsugu Uemura7
Correction to: B MC Urol (2020) 20:139 https://doi.org/10.1186/s12894-020-00689-0
In the original publication of this article [1] there were several errors in Table 1 related to the values for Disease status (nmCRPC and mCSPC). In this correction article the correct and incorrect values are shown. Table 1 The correct and incorrect values Incorrect
Correct
Disease status, n
Disease status, n
nmCRPC
55
–
–
55
nmCRPC
34
–
–
34
mCSPC
–
51
–
51
mCSPC
–
28
–
28
Furthermore, the Time-to-event analyses section has several errors with the decimal values/rounding of numbers, the incorrect and correct information is shown below The original article can be found online at https://doi.org/10.1186/s1289 4-020-00689-0. *Correspondence: [email protected] 2 Medical Affairs, Janssen Pharmaceutical K.K., Tokyo, Japan Full list of author information is available at the end of the article
Incorrect
Correct
66 days
66.0 days
45 days
45.0 days
52 days
52.0 days
38 days
38.0 days
82 days
82.0 days
In the global population of the SPARTAN study, skin rash of any grade resolved for 81% of the patients within 59.5 days, while the median time to resolution of skin rash of any grade in the TITAN study was 100 days (Sup‑ plementary Table 2)
In the global population of the SPARTAN study, skin rash of any grade resolved for 80.6% of the patients within 59.5 days, while the median time to resolution of skin rash of any grade in the TITAN study was 100.0 days (Supplemen‑ tary Table 2)
100 days
100.0 days
35 days
35.0 days
37 days
37.0 days
66 days
66.0 days
Author details 1 Department of Urology and Renal Transplantation, Yokohama City University Medical Center, Yokohama, Japan. 2 Medical Affairs, Janssen Pharmaceutical K.K., Tokyo, Japan. 3 Clinical Pharmacology, Janssen Pharmaceutical K.K, Tokyo, Japan. 4 Clinical Science, Janssen Pharmaceutical K.K, Tokyo, Japan. 5 Depart‑ ment of Dermatology, Yokohama City University Medical Center, Yokohama,
© The Author(s) 2020. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory reg
Data Loading...
